BC
VCYT icon

Broadfin Capital’s Veracyte VCYT Stock Holding History

Broadfin Capital’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-600,658
Closed -$3.34M – 57
2018
Q1 		$3.34M Sell
600,658
-145,700
-20% -$902K 0.52% 42
2017
Q4 		$4.87M Sell
746,358
-274,474
-27% -$2.04M 0.8% 29
2017
Q3 		$8.95M Sell
1,020,832
-426,034
-29% -$3.46M 1.32% 22
2017
Q2 		$12.1M Sell
1,446,866
-201,700
-12% -$1.65M 1.46% 24
2017
Q1 		$15.1M Sell
1,648,566
-139,700
-8% -$1.14M 1.83% 18
2016
Q4 		$13.8M Buy
+1,788,266
New +$13.4M 1.54% 18
2016
Q2 		– Sell
-97,298
Closed -$525K – 73
2016
Q1 		$525K Sell
97,298
-207,682
-68% -$1.23M 0.05% 71
2015
Q4 		$2.2M Sell
304,980
-431,216
-59% -$2.9M 0.14% 82
2015
Q3 		$3.45M Hold
736,196
– – 0.19% 73
2015
Q2 		$8.2M Buy
+736,196
New +$7.25M 0.44% 54

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Broadfin Capital's VCYT Position: Q2 2018 in Review

Broadfin Capital sold out of Veracyte (VCYT) in Q2 2018, closing a stake of 600,658 shares — an estimated $3.34M sold.

Broadfin Capital first reported a position in VCYT in Q2 2015 and held it in 10 quarters. The position peaked at $15.1M in Q1 2017. 75 funds tracked by Wall St. Rank hold VCYT as of Q2 2018.

  • Broadfin Capital reported no remaining Veracyte position as of Q2 2018 after selling out during the quarter.
  • Broadfin Capital sold 600,658 Veracyte shares in Q2 2018, an estimated $3.34M.
  • Broadfin Capital first reported a position in Veracyte in Q2 2015 and held it in 10 quarters.
  • Broadfin Capital's Veracyte position peaked at $15.1M in Q1 2017.
  • 75 funds tracked by Wall St. Rank held Veracyte as of Q2 2018.

Based on Broadfin Capital's 13F filing for Q2 2018, filed 14 Aug 2018.